Evidence map›Paper›PMID 35410525›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2022

Jing Li, Xuting Xu, Huilian Huang, Liqin Li, Jing Chen, Yunfeng Ding, Jinliang Ping

Open access · greenAbstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. PINK1 regulates apoptosis of osteosarcoma as the target gene of cisplatin.Journal of orthopaedic surgery and research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jing LiHuzhou Key Laboratory of Molecular Medicine, Huzhou Central Hospital, Affiliated Hospital of Huzhou Normal University, Huzhou 313000, China.ORCID 0000-0002-8045-6010
Xuting XuHuzhou Key Laboratory of Molecular Medicine, Huzhou Central Hospital, Affiliated Hospital of Huzhou Normal University, Huzhou 313000, China.
Huilian HuangHuzhou Key Laboratory of Molecular Medicine, Huzhou Central Hospital, Affiliated Hospital of Huzhou Normal University, Huzhou 313000, China.
Liqin LiHuzhou Key Laboratory of Molecular Medicine, Huzhou Central Hospital, Affiliated Hospital of Huzhou Normal University, Huzhou 313000, China.
Jing ChenHuzhou Key Laboratory of Molecular Medicine, Huzhou Central Hospital, Affiliated Hospital of Huzhou Normal University, Huzhou 313000, China.
Yunfeng DingDepartment of Breast Surgery, Huzhou Central Hospital, Affiliated Hospital of Huzhou Normal University, Huzhou 313000, China.
Jinliang PingDepartment of Pathology, Huzhou Central Hospital, Affiliated Hospital of Huzhou Normal University, Huzhou 313000, China.
Huzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphatase and tensin homolog (PTEN)-induced kinase 1 (

Indexed as

Breast NeoplasmsCell Line, TumorCell ProliferationFemaleGlycolysisHumansProteomicsbreast cancerglycolysisimmunohistochemistryMDA-MB-231Pink1

Identifiers

PMID35410525
PMCPMC9265526
OpenAlexW4223478942

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.